2018 - Member of the National Academy of Medicine (NAM)
2012 - William Beaumont Prize, American Gastroenterological Association (AGA)
Member of the Association of American Physicians
His primary areas of study are Immunology, Immune system, Antigen, Molecular biology and Immunoglobulin G. His research integrates issues of Intestinal mucosa and Inflammatory bowel disease in his study of Immunology. The concepts of his Immune system study are interwoven with issues in Viral disease, Cytokine, Cell adhesion molecule and Virology.
His Antigen study combines topics in areas such as Biochemistry, Antigen presentation and Pathogenesis. His Molecular biology research is multidisciplinary, incorporating perspectives in T cell, CD1, Antigen-presenting cell and CD8. His Immunoglobulin G research incorporates themes from Receptor, Histocompatibility Antigens Class I and Immunotherapy.
His primary scientific interests are in Immunology, Cell biology, Immune system, Molecular biology and Antigen. Immunology and Inflammatory bowel disease are frequently intertwined in his study. His study in Inflammatory bowel disease is interdisciplinary in nature, drawing from both Crohn's disease, Colitis, Pathogenesis and Ulcerative colitis.
His research in Cell biology intersects with topics in Receptor, Cell, Biochemistry and Intestinal mucosa. Immune system and Cell adhesion molecule are commonly linked in his work. His Molecular biology research includes themes of Cell culture and Intraepithelial lymphocyte.
His main research concerns Cell biology, Immune system, Immunology, Antibody and Inflammation. He interconnects Cell, Paneth cell and Intestinal mucosa in the investigation of issues within Cell biology. His work investigates the relationship between Immune system and topics such as Receptor that intersect with problems in T cell.
His studies deal with areas such as Disease and Inflammatory bowel disease as well as Immunology. His work focuses on many connections between Antibody and other disciplines, such as Cell adhesion molecule, that overlap with his field of interest in Mucin, Carcinoembryonic antigen, Function and Internal medicine. He combines subjects such as Gut flora, Colitis, Homeostasis and Natural killer T cell, CD1D with his study of Inflammation.
Richard S. Blumberg mainly focuses on Immune system, Cell biology, Immunology, Inflammation and Intestinal mucosa. His Immune system study combines topics from a wide range of disciplines, such as Receptor, Antibody and Bioinformatics. His work on Immunoglobulin G as part of general Antibody study is frequently linked to Phosphatidylserine, therefore connecting diverse disciplines of science.
His studies in Cell biology integrate themes in fields like Transcytosis, Albumin, Intestinal epithelium and Pathogenesis. His Inflammation research includes elements of Downregulation and upregulation, Stem cell, Mucous membrane, LGR5 and Notch signaling pathway. His research investigates the connection between Intestinal mucosa and topics such as Interleukin 22 that intersect with issues in Pancreatitis-Associated Proteins, Interleukin 23 and Colitis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison;Creg J. Workman;Timothy T. Kuo;Kelli Boyd.
The immunology of mucosal models of inflammation.
Warren Strober;Ivan J. Fuss;Richard S. Blumberg.
Annual Review of Immunology (2002)
Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function
Torsten Olszak;Dingding An;Sebastian Zeissig;Miguel Pinilla Vera.
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease
Arthur Kaser;Ann-Hwee Lee;Andre Franke;Jonathan N. Glickman.
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Ken Sugimoto;Atsuhiro Ogawa;Atsuhiro Ogawa;Emiko Mizoguchi;Yasuyo Shimomura.
Journal of Clinical Investigation (2008)
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation.
Atsushi Mizoguchi;Emiko Mizoguchi;Hidetoshi Takedatsu;Richard S Blumberg;Richard S Blumberg.
HIV-specific cytotoxic T lymphocytes in seropositive individuals.
Bruce D. Walker;Sekhar Chakrabarti;Bernard Moss;Timothy J. Paradis.
Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis
Ivan J. Fuss;Frank Heller;Monica Boirivant;Francisco Leon.
Journal of Clinical Investigation (2004)
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes
Imke Tiede;Gerhard Fritz;Susanne Strand;Daniela Poppe.
Journal of Clinical Investigation (2003)
Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells.
Frank Heller;Ivan J Fuss;Edward E Nieuwenhuis;Edward E Nieuwenhuis;Richard S Blumberg.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: